ING Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $981K | Sell |
|
|||||
|
2025
Q1 | $983K | Sell |
|
|||||
|
2024
Q4 | $1.21M | Sell |
|
|||||
|
2024
Q3 | $1.36M | Sell |
|
|||||
|
2024
Q2 | $1.43M | Sell |
|
|||||
|
2024
Q1 | $1.9M | Buy |
|
|||||
|
2023
Q4 | $1.66M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.74M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.57M | Sell |
|
|||||
|
2022
Q2 | $2.05M | Buy |
|
|||||
|
2022
Q1 | $2.27M | Buy |
|
|||||
|
2021
Q4 | $2.48M | Buy |
|
|||||
|
2021
Q3 | $1.75M | Buy |
|
|||||
|
2021
Q2 | $1.53M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $1.07M | Buy |
|
|||||
|
2018
Q4 | $834K | Buy |
|
|||||
|
2018
Q3 | $988K | Buy |
|
|||||
|
2018
Q2 | $824K | Buy |
|
|||||
|
2018
Q1 | $770K | Buy |
|
|||||
|
2017
Q4 | $782K | Buy |
|
|||||
|
2017
Q3 | $630K | Buy |
|
|||||
|
2017
Q2 | $586K | Buy |
|